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Hand/Peripheral Nerve
Patient-Reported Disability Measures Do Not
Correlate with Electrodiagnostic Severity in Carpal
Tunnel Syndrome
Jacob E. Tulipan, MD*
Kevin F. Lutsky, MD†
Mitchell G. Maltenfort, PhD†
Mitchell K. Freedman, MD†
Pedro K. Beredjiklian, MD†

Background: Electrophysiologic studies including electromyography and nerve
conduction studies play a role in the evaluation of carpal tunnel syndrome (CTS),
despite evidence that these studies do not correlate with CTS-specific symptom
scores. There is a lack of evidence comparing electrophysiologic data with general
measures of function.
Methods: Fifty patients presenting for CTS treatment over an 8-month period were
analyzed retrospectively. All patients completed surveys including the Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH) and the Medical
Outcomes Study 12-Item Short-Form Survey [(physical component summary 12,
mental component summary (MCS-12)]. Electromyography and nerve conduction
studies were performed on all patients and compared with outcome scores.
Results: Analysis demonstrated no relationship between DASH or MCS-12 and
electrodiagnostic severity. No significant correlations were noted between DASH
or MCS-12 and median motor or sensory latency. There was a moderate–weak correlation (rho = 0.34) between more severe electrophysiologic grade and better
function based on physical component summary 12.
Conclusions: Electrodiagnostic severity grades do not correlate with patientreported disability, including the DASH and MCS–12 surveys. There is a counterintuitive correlation between more-severe electrodiagnostic findings and decreased
physical disability. These findings indicate that disability may not correlate with electrodiagnostic severity of median neuropathy in CTS. (Plast Reconstr Surg Glob Open
2017;5:e1440; doi: 10.1097/GOX.0000000000001440; Published online 11 August 2017.)

INTRODUCTION

Although history and physical alone can be sufficient
to diagnose carpal tunnel syndrome (CTS), electrophysiologic studies including electromyography and nerve
conduction studies (EMG/NCS) continue to play an important role in the evaluation of this condition.1–3 Electrodiagnostic findings have been compared with a number of
specific symptom scoring tools, including the CTS Assessment Questionnaire,4,5 CTS-6 scale,6 and the McGill pain
questionnaire.7
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The 12-item Short Form Health Survey (SF-12) is a general measure of physical and mental health function used
for monitoring of chronic conditions. We chose to use the
SF-12 score because it is reflective of a more general assessment of the impact of a patient’s condition on their overall health and well-being.8 It allows calculation of a physical
component summary (PCS-12) and mental component
summary (MCS-12) to evaluate patient health along these
axes.9 Questions are more broadly focused on patients’ experience of their general daily function. This instrument
allows researchers to capture nonspecific symptoms and
patient experience more broadly than more specific scores
like DASH. Furthermore, it allows evaluation of the mental
component of patient health, which plays a clear role in patient disability. The purpose of the present study was to assess
the relationship between English-language patient-reported
functional scores and EMG/NCS findings in patients with
CTS. We hypothesize that electrodiagnostic findings in patients with CTS do not correlate with patient-reported functional disability as measured by validated outcome surveys.
Disclosure: The authors have no financial interest to
declare in relation to the content of this article. The Article
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METHODS

Our institutional review board approved this cross-sectional study protocol. We retrospectively analyzed patients
with a diagnosis of CTS who presented for treatment to
our group of fellowship-trained, orthopedic hand surgeons between April and December 2015. The study size
was set at 50 patients based on a preliminary power analysis. The diagnosis was based on clinical history, physical
examination, and EMG/NCS evaluation. Inclusion criteria consisted of EMG/NCS performed within 3 months of
presentation. Patients with trauma-related onset of symptoms, previous surgery for CTS, patients with negative
electrodiagnostic studies, and those with concomitant upper extremity compression neuropathies were excluded
from the study.
Patient age and gender were recorded. All patients
completed self-reported health and disability scores, including the Quick Disabilities of the Arm, Shoulder, and
Hand questionnaire (DASH) and the Medical Outcomes
Study 12-Item SF-12. Although the DASH scores are inversely proportional to functional status (a lower score
reflects higher function), the SF-12 [physical (PCS-12)
and mental (MCS-12) spheres] are directly proportional
to function.
Electrodiagnostic studies were the reference standard
for the diagnosis of CTS, consisted of nerve conduction
studies and electromyography. The studies were performed
by Physical Medicine and Rehabilitation specialists in our
group according to the guidelines of the American Association of Neuromuscular and Electrodiagnostic Medicine.10,11
All the electromyographers have agreed on the basic protocols used to assess CTS and are part of a laboratory, which
is certified by the American Association of Neuromuscular
and Electrodiagnostic Medicine. EMG and NCS were performed on all patients in conjunction with a history and
physical. Temperature of the upper extremity was maintained at 32 degrees Celsius. Temperatures lower than
32 degrees can result in prolonged distal latency of motor
and sensory studies and slowing of conduction velocities.12
NCS consisted of evaluation of median and ulnar motor and sensory nerves in the symptomatic upper extremity and compared findings with absolute normal values and
relative values between the contralateral median nerve
and ipsilateral ulnar nerve. Median and ulnar sensory
nerve action potentials were obtained by stimulating the
nerve in the forearm 14 cm proximal to the “active” electrode, which picks up the electrical impulse at the base of
the index finger and the proximal interphalangeal joint
of the small finger, respectively. Motor nerve action potentials were achieved by stimulating the median nerve 8 cm
proximal to the “active” electrode, which is over the midpoint of the abductor pollicis brevis and the ulnar nerve
8 cm proximal to the abductor digiti minimi. Transcarpal
studies are very sensitive studies that are used to diagnose
subtle CTS in patients with convincing symptoms who did
not have abnormal electrical findings with conventional
motor and sensory studies. Transcarpal studies are mixed
sensory-motor studies that involve stimulation over the
midpalm and recording from the active elecrode, which
is 8 cm proximal to the midpalm the ulnar and median
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nerves. The time that it takes to travel from the stimulating electrode to the active electrode is called the distal
latency. The size of the electrical potential is called the
amplitude.
Needle examination was routinely performed on a sampling of muscles that are innervated by the C5–T1 nerve
roots, brachial plexus, and peripheral nerves of the upper extremity. Muscle screen standardly included biceps,
pronator teres, triceps, abductor pollicis brevis, first dorsal interosseous, and if radiculopathy was suspected, the
cervical paraspinal musculature was also evaluated. Each
muscle was evaluated for spontaneous electrical potentials
(positive waves, fibrillations). The degree of spontaneous activity was graded between 0 and 4. Submaximal and
maximal contraction of the musculature were performed
to evaluate patients for polyphasicity, size of the electrical
potentials, and repetitive firing that are indicators of chronicity and severity of injury.
Distal sensory latencies greater than 3.6 ms and/or distal motor latencies greater than 4.4 ms were considered diagnostic for CTS.13 For all patients, median nerve sensory
and motor latencies, and electromyographic changes were
recorded. In addition, the neuropathy was graded mild,
moderate, or severe according to the criteria of Werner
and Andary,14 with evidence of sensory involvement considered “mild” CTS, sensory and motor involvement considered “moderate” CTS, and evidence of axonal changes
(including needle EMG changes or severe signal amplitude loss) considered “severe” CTS.
Statistical analysis was performed using R (R foundation for Statistical computing, Vienna, Austria). A 2-sided
Spearman rank analysis was used to correlate CTS electrodiagnostic severity with DASH and SF-12 outcomes. A
post hoc power analysis of our sample demonstrated 80%
power to detect a correlation of rho = 0.39. Rho values
of 0.30 are considered the minimum clinically significant
correlation.15 A linear regression was used to correlate
nerve conduction latency with DASH and SF-12 scores.

RESULTS

One hundred five consecutive patients were evaluated
for inclusion in this study, and a total of 50 met inclusion
criteria. There were 34 women and 16 men included in
the study with an average age of 58.6 years (range, 26–86
years). Based on electrophysiologist’s rating, there were
18 patients with electrophysiologically severe CTS (36%),
23 with moderate CTS (46%), and 9 with mild CTS (18%).
The average DASH and SF-12 scores are reported
in Table 1. Spearman’s rank analysis demonstrated no
statistically significant correlation between DASH and
electrodiagnostic severity (rho = ˗0.18; P = 0.08). There
was no significant correlation between MCS-12 and electrodiagnostic median neuropathy severity (rho = 0.149;
P = 0.18). A statistically significant correlation was noted
between the PCS-12 value and electrodiagnostic severity
(rho = 0.34; P = 0.002). Pearson’s correlation coefficient
measured 0.096 for the relationship between PCS-12 and
patient age, demonstrating a minimal effect of age on
PCS-12 in our sample (Fig. 1).
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Table 1. Correlation between Disability Scores and
Electrodiagnostic Severity
Survey

Mild

DASH
PCS-12
MCS-12

50.07
30.22
46.7

Moderate
30.49
40.25
53.48

Severe
34.5
41.48
55.06

Spearman Rank
Coefficient Rho
˗0.179
0.335
0.149

P
0.08
0.002*
0.18

*P < 0.05

No statistically significant correlations were noted between DASH, PCS-12, or MCS-12 and median motor or
sensory latency at the wrist (Table 2; Fig. 2).

DISCUSSION

The purpose of this study was to assess the relationship between severity of electrodiagnostic findings and
validated instruments measuring function and disability
in patients presenting to hand surgeons for management
of CTS. Based on our data, it appears that electrodiagnostic severity, based on an electrical grading system or on
measured median nerve latency, does not correlate with
patient-derived measures of disability in patients with CTS.
In other words, it appears that dysfunction in these pa-

tients does not correlate to the electrophysiologic degree
of nerve compression, but may rather be dependent on
other factors. Depression, anxiety, catastrophization, and
misinterpretation of pain have been shown to correlate
with patient distress and could account for the variability in
reported dysfunction that is not explained by electrophysiologic parameters.16–18 Furthermore, disability secondary
to CTS may be more likely with certain vocations, a variable
not assessed in this study.
Previous studies have failed to link objective findings
to symptom severity scales in patients with CTS. Levine
et al.5 developed a carpal-tunnel–specific questionnaire
based on the frequency and severity of classic carpal tunnel symptoms such as tingling, numbness, weakness, and
sleep disturbance as well as ability to complete daily activities. This scale was found to be reproducible and consistent but correlated poorly with objective measures of
sensory neuropathy such as Semmes-Weinstein monofilament testing.5 The authors did not correlate their findings with EMG/NCS results. Makanji et al.6 compared
motor and sensory latencies to score on the CTS-6 and
Levine questionnaires, among other pain scales. The
CTS-6 scale showed limited correlation with motor and
sensory latencies, whereas the Levine scale did not. In

Fig. 1. Correlation between outcome scores and age. A, Short-Form 12 Health Survey Mental Component versus age. B, Short-Form 12
Health Survey Physical Component versus age. C, Disabilities of the arm, shoulder, and hand survey versus age.
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Table 2. Correlation between Disability Scores and Latency
Electrodiagnostic
Parameters
Median sensory latency
Median motor latency

Versus
DASH

Versus
MCS-12

Versus
PCS-12

Rho

P

Rho

P

Rho

P

˗0.06
˗0.039

0.679
0.74

0.23
0.24

0.098
0.052

0.15
0.24

0.285
0.052

*P < 0.05. Rho = 0.30 is considered the minimum clinically significant
correlation.19

addition, the authors found no significant difference
in Levine scale scores and CTS-6–derived probability in
patients categorized as having mild, moderate, or severe
CTS. In a 2015 study,19 CTS-6 scores were found to be
significantly higher in patients with electrodiagnostically severe disease versus those with electrodiagnostically
moderate disease (3.1 versus 2.7). This study, however,
did not specifically examine objective measures such as
latency values and used a different (and older) set of
electrodiagnostic criteria than the American Association
of Neuromuscular and Electrodiagnostic Medicine14 criteria used in this study.

Chan et al.4 evaluated the correlation between electrodiagnostic studies and the CTS Assessment Questionnaire
functional status scale. The authors found no statistically
significant relationships between the electrodiagnostic
findings and functional status and symptom severity.4
Although our study reaches a similar conclusion, the
outcome measures used in our study (DASH, SF-12) are
general measures of extremity function and disability. As
such, this study differs from previous ones in the generality of the outcome scores—that is, it does not examine
symptoms specifically related to CTS. Patients with CTS
can struggle to define their symptomatology, and the description of these symptoms varies by patient, culture, and
location.20,21
Electrodiagnostic findings have also been compared
with scores on the DASH. Bakhsh et al.,22 in a 2012 study,
found no correlation between DASH scores and individual
electrodiagnostic parameters. The authors did not provide
any electromyographic data, and as such the correlation of
DASH score with nerve conduction parameters is of limited value relative to the categorization of CTS severity.22 In
a similar study, Itsubo et al.23 demonstrated a weak correla-

Fig. 2. Correlation between mental and physical SF-12 components and nerve conduction latency. A, Median motor latency in ms versus
Short-Form 12 Health Survey Mental Component. B, Median motor latency in ms versus Short-Form 12 Health Survey Physical Component. C, Median sensory latency in ms versus Short-Form 12 Health Survey Mental Component. D, Median sensory latency in ms versus
Short-Form 12 Health Survey Physical Component. Shaded areas represent 95% confidence band.
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tion (correlation coefficient, 0.36) between electrophysiologic grade (mild/moderate/severe) and the Japanese
QuickDASH but failed to find any correlation between
QuickDASH and specific electrophysiologic parameters.
The authors used median nerve latency and velocity to categorize CTS severity, a significant limitation of this study.
The SF-12 was evaluated for use in CTS by Bessette et al.
in a 1998 study,24 but no attempt was made to elucidate the
relationship between SF-12 score and preoperative CTS
electrodiagnostic severity. A 2006 study comparing open
and endoscopic carpal tunnel release also measured SF-12
pre-and postoperatively but again did not attempt to correlate disease severity and SF-12 score.25
We found a statistically significant correlation between
electrodiagnostic severity based on electrodiagnostic grading and PCS-12. The positive correlation (r = 0.34) indicates
that the patients presenting with electrodiagnostic evidence
of more severe pathology reported less physical disability
(higher PCS-12), which is counterintuitive and supports the
notion that the electrical grading system is not useful to predict disability. We cannot definitively explain the correlation
between less severe electrophysiologic grade and higher
reported disability. It may be that patients with newer onset symptoms (and therefore milder grade) have not compensated for this condition in the same way as patients with
more severe (and presumably longer duration of) symptoms.
There may also be a self-selection bias in that those patients
who experience their disability more strongly may present
earlier in the disease course. Finally, since the strength of this
correlation was moderate-low and the results of this finding
are counterintuitive, this lends further support to our overall
conclusions that electrophysiologic measures do not correspond well to patient-reported disability scores.
Nerve conduction studies evaluate large nerve fibers
responsible for motor and proprioceptive function, rather
than the small c fibers responsible for pain transmission
and paresthesias. Patients may thus experience symptomatology due to dysfunction of these small fibers, which is
not detected by nerve conduction studies. None of this is
factored into the grading system, which is why grading systems can be controversial in the evaluation of CTS.26–28 Linear regression analysis confirmed the lack of correlation
between median motor and sensory latency and disability,
supporting our findings that patient-rated dysfunction appear to be unrelated to electrodiagnostic findings.
Limitations of this study include a small patient cohort
and the retrospective nature of this study. Although a post
hoc power analysis demonstrated an ability to detect a rho
value of 0.38 or greater, there is a possibility that a weaker
but statistically significant correlation exists. Although it is
possible that this limitation could be improved by including
a greater number of patients, it is likely that such a weak correlation would have limited clinical value. Second, the study
also fails to account for symptom duration. Patients with longer symptom duration may report higher or lower levels of
disability. Given the often-insidious onset of CTS symptoms,
exact time of disease onset is difficult to determine. Furthermore, it is difficult to separate longer-duration CTS from
worsening CTS. Further studies obtaining longitudinal data
will be required to evaluate the effect of symptom duration

on patient disability. Third, bias may have been introduced
by patient awareness of electrophysiologic test results. Our
clinical protocol did not specifically address electrophysiologist discussion and interpretation of the results with the patient. As a result, patients may have known of their diagnosis
of “mild, moderate, or severe” CTS at the time they filled out
their surveys, potentially affecting their responses.
Based on the results of this study, it appears that the severity of electrodiagnostic studies does not correlate with
patient function using validated patient outcome measures generalized for the upper extremity in CTS. Further
studies evaluating the factors accounting for patients’ perceived disability could improve treatment and outcomes
for this common clinical condition.
Pedro K. Beredjiklian, MD
925 Chestnut Street
Philadelphia, PA 19107
E-mail: pedro.beredjiklian@rothmaninstitute.com
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